State of The Science Summit:
Diagnosis of Trauma-Related Brain Disorders

September 12-13, 2018 | Silver Spring, MD

 

BRAIN TRAUMA BLUEPRINT

The Brain Trauma Blueprint is a series of State of the Science Summits aimed to accelerate an era of personalized medicine for survivors of brain trauma. By fostering collaboration across the broader stakeholder community, we will enable translational research gaps to be bridged and achieve solutions sooner for those suffering from trauma-related brain disorders.

The need is significant.

  • Most people will experience at least one traumatic event in their lifetime.
  • Estimates suggest approximately 24.4 million Americans have PTSD.
  • An average of 2.8 million Americans will experience a traumatic brain injury every year.
  • Recent research suggests that even a single concussive event may cause neurocognitive changes in individuals at any point post-injury.
  • The morbidity and mortality of PTSD and chronic neuropsychiatric effects of TBI are further magnified by the substantial disruptions in family, workplace, and societal contexts, all contributing to the enormous clinical, social, and financial burden of ineffectively treated trauma-related brain disorders.
  • There is a paucity of therapeutic options for these conditions.
  • The developmental pipeline is meager compared with other prevalent CNS disorders.
  • There are no objective diagnostics for PTSD or for the chronic neuropsychiatric effects of TBI.
  • These disorders also lack validated treatment response and prognostic biomarkers and objective outcome measures.
  • This situation is related to and exacerbated by the limited understanding of the biological underpinnings of these disorders.

Brain Trauma Blueprint - State of the Science Summit

 

Addressing these translational research gaps requires coordinated involvement from multidisciplinary and cross-sector champions of scientific research and innovative clinical implementation, including:

TOGETHER, WE WILL EMPOWER ALL STAKEHOLDERS TO BE INFORMED AND STRATEGIC ARCHITECTS OF THEIR OWN TRANSLATIONAL RESEARCH TRAUMA BLUEPRINT.